Data were analyzed using one-way ANOVA to compare
the baseline values for demographic, anthropometric, and
clinical characteristics. The Chi square test was used for
the analysis of categorical variables and repeated measure
ANOVA for the primary efficacy and safety parameters,
i.e., clinical assessment from day 0 to day 42, and when
found significant Bonferroni’s post hoc test and mixed
model analysis to assess the effect of pharmacologicalintervention among the groups as per intension to treat
[ITT] principle. p value less than 0.05 was considered as
statistically significant.